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Abstract
Motivation: The inference of genes that are truly associated with inherited human diseases from a set of
candidates resulting from genetic linkage studies has been one of the most challenging tasks in human genetics.
Although several computational approaches have been proposed to prioritize candidate genes relying on protein-
protein interaction (PPI) networks, these methods can usually cover less than half of known human genes.
Results: We propose to rely on the biological process domain of the gene ontology to construct a gene semantic
similarity network and then use the network to infer disease genes. We show that the constructed network covers
about 50% more genes than a typical PPI network. By analyzing the gene semantic similarity network with the PPI
network, we show that gene pairs tend to have higher semantic similarity scores if the corresponding proteins are
closer to each other in the PPI network. By analyzing the gene semantic similarity network with a phenotype
similarity network, we show that semantic similarity scores of genes associated with similar diseases are
significantly different from those of genes selected at random, and that genes with higher semantic similarity
scores tend to be associated with diseases with higher phenotype similarity scores. We further use the gene
semantic similarity network with a random walk with restart model to infer disease genes. Through a series of
large-scale leave-one-out cross-validation experiments, we show that the gene semantic similarity network can
achieve not only higher coverage but also higher accuracy than the PPI network in the inference of disease genes.
Contactruijiang@tsinghua.edu.cn
Background
Not withstanding the remarkable success of such statisti-
cal methods as linkage analysis and association studies in
identifying genetic variants underlying inherited human
diseases in the past few decades [1], susceptibility geno-
mic regions obtained by these methods may contain doz-
ens or even hundreds of candidate genes, appealing for
the development of effective computational methods to
infer genes that are truly associated with a query disease
of interest from a long list of candidates [2].
In the face of this challenge, several methods have
been proposed to score genes in a candidate list accord-
ing to their functional relevance to the genes that are
already known to be associated with the query disease
(i.e., seed genes) and then prioritize the candidates
according to their scores. The basic assumption of these
methods, which is typically referred to as the “guilt-by-
direct-association” principle, is that genes associated
with a disease should have similar functions. It is there-
fore crucial for these methods to estimate functional
similarity between genes. For this purpose, a wide vari-
ety of genomic information has been adopted, with
examples including protein sequences [3], gene expres-
sion profiles [4], literature descriptions [5], protein-pro-
tein interactions (PPI) [6], gene ontology annotations
[7], and many others [8]. Methods using multiple geno-
mic data sources have also been proposed [9,10].
Depending on seed genes to prioritize candidate genes
will restrict the scope of application of the above meth-
ods, because genetic bases for about half of the known
* Correspondence: ruijiang@tsinghua.edu.cn
1MOE Key Laboratory of Bioinformatics and Bioinformatics Division, TNLIST/
Department of Automation, Tsinghua University, Beijing 100084, China
Full list of author information is available at the end of the article
Jiang et al. BMC Systems Biology 2011, 5(Suppl 2):S2
http://www.biomedcentral.com/1752-0509/5/S2/S2
© 2011 Jiang et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.human diseases are completely unknown according to
t h eO n l i n eM e n d e l i a nI n h e r i t a n c ei nM a n( O M I M )
database [11]. To overcome this limitation, recent stu-
dies have suggested the “guilt-by-indirect-association”
principle, which relies on the modular nature of inher-
ited human diseases [8,12] and resorts to a phenotype
similarity network of diseases [13] to prioritize candidate
genes [14-17,20]. These methods successfully extend the
scope of prioritizing candidate genes to diseases whose
genetic bases are completely unknown.
However, all methods based on the “guilt-by-indirect-
association” principle thus far are designed to be used
with one or more protein-protein interaction networks.
For example, Wu et al. used a linear regression model
to explain phenotype similarity using protein network
proximity [15]. Zhang et al. extend the regression model
to include multiple protein-protein interaction networks
[19]. Li and Patra utilized a random walk model to
simulate the steady-state probability of a random walker
staying at a gene [17]. Although a protein-protein inter-
action network could provide a simplified yet systematic
view of functional relationships between genes, the cov-
erage of available protein-protein interaction networks is
typically low, and the reliability of different protein-pro-
tein interaction networks is quite different [19], making
the selection of a suitable network far from trivial.
Moreover, focusing on common interactions in multiple
networks to improve the confidence of edges will sacri-
fice the coverage of the resulting network, while focus-
ing on the union of interactions to improve the
coverage will result in a network of low reliability [19].
Motivated by these observations, we propose to con-
struct a gene semantic similarity network using the bio-
logical process domain of gene ontology and GO
annotations of human genes. We show that the gene
semantic similarity network covers 14,085 genes, about
50% more genes than the widely used Human Protein
Reference Database (HPRD) [21] protein-protein inter-
action network. Via a comprehensive analysis of the
gene semantic similarity network with the HPRD net-
work, we show that gene pairs tend to have higher
semantic similarity scores if the corresponding proteins
are closer to each other in the HPRD network. Through
a detailed analysis of the gene semantic similarity net-
work with a phenotype similarity network, we show that
semantic similarity scores of genes associated with simi-
lar diseases are significantly different from those of
genes selected at random, and that genes with higher
semantic similarity scores tend to be associated with dis-
eases with higher phenotype similarity scores. We
further use the gene semantic similarity network with a
random walk with restart model [17] to infer disease
genes. Through a series of large-scale leave-one-out
cross-validation experiments, we show that the gene
semantic similarity network can achieve not only higher
coverage but also higher accuracy than the HPRD net-
work in the inference of disease genes. With these
results, we conjecture that the gene semantic similarity
network can serve as a better assessment of functional
relationship between genes and then be used in a large
number of applications in systems biology.
Results
Data sources
We propose to prioritize candidate genes using 1) a
gene semantic similarity network that is constructed
using the biological process (BP) domain of the gene
ontology (GO) and known GO annotations of human
proteins, 2) a phenotype similarity network of human
diseases, and 3) known associations between diseases
and genes.
First, we extract 18, 850 GO terms in the biological
process domain from the gene ontology (released on
April 18, 2010) and extract 186, 080 annotations of
human proteins from the UniProtKB GO annotations of
human proteins (released on April 18, 2010). Focusing
on proteins with corresponding gene identifiers in the
Ensembl database, we obtain 59,681 annotations that
involve 14,085 human genes and 5,596 GO terms.
Second, we obtain a phenotype similarity profile,
represented as a matrix of similarity scores between
5,080 human diseases, from the literature [13]. Since
most small similarity scores in this profile are likely to
be noise and only high scores have clear biological
meanings [13], we follow the literature [17] to keep the
first five nearest neighbors for each disease and obtain a
phenotype similarity network, in which vertices are
human diseases and weighted edges indicate similarity
scores between diseases.
Third, we use the tool BioMart [22] to extract 4, 368
known associations that involve 2,593 human genes
with Ensembl gene identifier and 3, 111 human diseases
in the OMIM database [11].
Finally, we use the high quality Human Protein Refer-
ence Database (HPRD) [21] to demonstrate the relation-
ship between a gene semantic similarity network and a
protein-protein interaction network. After removing
duplications and self-linked interactions, we extract
from release 9 (release on April 13, 2010) of this data-
base 37, 067 interactions between 9,518 human genes.
Construction of gene semantic similarity networks
The procedure of constructing a gene semantic similarity
network is illustrated in Figure 1. First, we calculate pair-
wise semantic similarity scores for GO terms in the biolo-
gical process domain, obtaining a matrix that contains
semantic similarity scores between GO terms. Next, we
calculate pairwise semantic similarity scores for human
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of genes, obtaining a matrix that contains semantic simi-
larity scores between genes. Then, we filter out low simi-
larity values in this matrix by keeping only the first 
nearest neighbors for each gene and assigning zeros to all
other elements. Finally, we obtain a gene semantic similar-
ity network by treating non-zero elements in the resulting
matrix as weights of edges between corresponding genes.
We adopt three methods based on information con-
tents of GO terms (Resnik [23], Schlicker et al. [24] and
Lin [25]) and one method based on the structure of gene
ontology (Wang et al. [26]) to calculate similarity scores
for GO terms, and we use a method in the literature [26]
to calculate similarity scores for genes (see Methods for
details). Hence, we obtain four semantic similarity net-
works, each containing 14,085 human genes.
Gene semantic similarity correlates with protein network
proximity
There have been a few methods relying on protein-pro-
tein interaction networks to infer disease genes [17].
The basic assumption of these methods is that interact-
ing proteins are usually related in their functions, and
thus the proximity of two proteins in a protein-protein
interaction network can be used as an estimation of the
functional relationship between the corresponding
genes. Therefore, we first show that the similarity score
between two genes in a gene semantic similarity net-
work correlates with the proximity score of the corre-
sponding proteins in a protein-protein interaction
network.
We use the length of the shortest path between two
proteins in the HPRD network to measure their proxi-
mity, and we draw box plots to demonstrate the rela-
tionship between gene semantic similarity scores and
protein network proximity scores in Figure 2. From the
figure, we can clearly see that gene pairs tend to have
higher semantic similarity scores if the corresponding
proteins are closer in the protein-protein interaction
network. Taking gene semantic similarity scores calcu-
lated using the method of Resnik as an example (Figure
2:A), the median semantic similarity score is 0.1760 for
Figure 1 Illustration of the procedure for constructing a gene semantic similarity network.
Figure 2 Relationship of gene similarity scores and protein network proximity scores. A: results for the method of Resnik. B: results for the
method of Schlicker et al. C: results for the method of Lin. D: results for the method of Wang et al.
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HPRD, 0.1322 for gene pairs intermediated by another
gene in HPRD, 0.1028 for gene pairs intermediated by
two other genes, 0.0830 for gene pairs intermediated by
three other genes, and 0.0698 for gene pairs interme-
diated by four or more other genes. Similar results are
observed for gene semantic similarity scores calculated
using the other methods.
These results suggest that gene semantic similarity
scores are correlated with protein proximity scores.
Hence, given the successful applications of [14-20], it is
reasonable to use gene semantic similarity networks for
the inference of disease genes.
Gene semantic similarity implies disease phenotype
similarity
The phenotype similarity profile of diseases has been
successfully used for prioritizing candidate genes in
recent studies [14-20]. In general, methods relying on
the phenotype similarity profile assume that similar dis-
eases are associated by genes with similar functions. It is
therefore necessary to assess whether semantic similarity
scores between genes associated with similar diseases
are significantly different from those between genes that
are selected at random. For this purpose, we partition
genes into 7 groups according to the similarity scores of
diseases that the genes are associated, and we draw the
box plot of pairwise similarity scores of genes in each
group in Figure 3.
We use gene semantic similarity scores calculated
using the method of Resnik as an example to demon-
strate the relationship between gene semantic similarity
and disease phenotype similarity (Figure 3:A). In group
1, we look at each disease separately. We collect genes
that are associated with a disease, plot pairwise semantic
similarity scores of these genes, and obtain a median
semantic similarity score of 0.1945 for this group of
genes. In group 2, we look at the nearest neighbor (the
disease with the highest similarity score) of each disease
in the disease similarity network. We collect genes asso-
ciated with a disease and genes associated with the near-
est neighbor of the disease, and we obtain a median
pairwise semantic similarity score of 0.1635 for this
group of genes. In group 3, we look at the second near-
est neighbor of each disease in the disease similarity net-
work. We collect genes that are associated with a
disease and its second nearest neighbor, and we obtain a
median pairwise semantic similarity score of 0.1486 for
this group of genes. Similarly, in groups 4, 5 and 6, we
look at the third, fourth and fifth nearest neighbor of
each disease, respectively, and we obtain median pair-
wise semantic similarity scores of 0.1441, 0.1394 and
0.1383 for the corresponding groups of genes, respec-
tively. Finally, in group 7, we look at 10,000 pairs of
genes that are selected at random, and we obtain a med-
ian pairwise semantic similarity score of 0.0649.
These results demonstrate that semantic similarity
scores of genes associated with similar diseases are sig-
nificantly different from those of genes selected at ran-
dom, and that genes with higher semantic similarity
scores tend to be associated with diseases with higher
phenotype similarity scores. In other words, semantic
similarity of genes implies phenotype similarity of dis-
eases that the genes are associated.
Figure 3 Pairwise semantic similarity scores of genes in different groups. A: results for the method of Resnik. B: results for the method of
Schlicker et al. C: results for the method of Lin. D: results for the method of Wang et al.
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in prioritizing candidate genes
We propose to prioritize candidate genes using a gene
semantic similarity network, the phenotype similarity
network, and known associations between diseases and
genes. This is done by applying a random walk with
restart model to a heterogeneous network that is com-
posed of both diseases and genes (see Methods). We
adopt two large-scale leave-one-out cross-validation
experiments with two comprehensive evaluation criteria
to assess the performance of this approach (see Meth-
ods), and we present results in Table 1 and Figure 4.
We use the gene semantic similarity network con-
structed using the method of Resnik as an example to
demonstrate the performance of the proposed approach.
At the threshold  = 100, we obtain a network com-
posed of 14, 085 genes and 2,112, 750 edges. Taking the
overlap of genes in this network and those in the HPRD
database, we obtain 8, 286 genes. Focusing on these
genes, we obtain 2,397 associations between 1,572 dis-
eases and 1,391 genes. We then perform the leave-one-
out cross-validation experiment against a linkage inter-
val and obtain the Mean Rank Ratio of disease genes
(MRR) as 10.60% and the Area Under the rank receiver
characteristic Curve (AUC) as 90.30%. We further per-
form the validation experiment against random genes
a n do b t a i na nM R Ro f1 0 . 6 5 %a n da nA U Co f9 0 . 2 5 % .
Since a random guess will yield an MRR of 50% and an
AUC of 50%, these results clearly suggest the effective-
ness of relying on the semantic similarity network to
uncover disease genes. For gene semantic similarity net-
works constructed using the other methods, we obtain
similar results (Table 1).
We replace the gene semantic similarity network with
the HPRD network and repeat the experiments. In the
validation of a linkage interval, we obtain an MRR of
14.21% and an AUC of 86.65%. In the validation of ran-
dom genes, we obtain an MRR of 14.40% and an AUC
of 86.46%. We further plot the ROC curves of the vali-
dation results in Figure 4, from which we observe that
the curves for the gene semantic similarity networks
climb much faster towards the top left corner of the
plot than that for the HPRD network. From these
results, we conclude that the gene semantic similarity
networks are superior to the HPRD network in the
prioritization of candidate genes.
We assess the influence of the threshold  on the per-
formance of the random walk model. We vary this para-
meter from 10 to 300 with step 10, perform the
validation against a linkage interval at each value, and
present the results in Figure 5. First, we observe that a
relatively small  for filtering out low semantic similarity
scores will improve the performance of the prioritization
method. For example, with the use of the semantic simi-
larity network constructed using the method of Resnik,
we obtain an MRR of 13.36% and an AUC of 87.51%
when using all similarity scores without filtration (corre-
sponding to  ≥ 14, 085). However, when using  =
100, we obtain an MRR of 10.60% and an AUC of
90.30%, indicating a significant improvement against the
results without filtration. Second, we observe that the
prioritization method is not sensitive to this parameter
when it is relatively small (compared with the number
of genes in the network). For example, when using the
method of Resnik, both the MRR and the AUC are
stable when 100 ≤  ≤ 300. The optimal value of  in
this interval is 180, at which we obtain an MRR of
10.45% and an AUC of 90.46%, only slightly better than
the results at  = 100. This property is important to the
selection of the parameter . More specifically, since the
performance of the prioritization method is only slightly
affected by  when it is relatively small, we can roughly
select a  value to obtain near optimal performance.
Hence, we default  to 100 in the rest of this paper
unless declaring explicitly.
Gene semantic similarity networks improve the coverage
in prioritizing candidate genes
The reliability and coverage of existing protein-protein
interaction data sets are quite different. Focusing on
common interactions in these data sets to improve the
confidence will sacrifice the coverage; considering the
union of interactions to improve the coverage will result
in a network of low reliability. A gene semantic similar-
ity network, however, can cover a large proportion of
human genes while providing high accurate inference of
disease genes.
We focus on the network constructed using the
method of Resnik to demonstrate the effectiveness of
relying on gene semantic similarity networks to infer
disease genes. At the threshold  = 100, we obtain a
network composed of 14,085 genes and 2,112,750 edges.
Focusing on these genes, we obtain 3,047 associations
between 1,984 diseases and 1,877 genes. We then
Table 1 Performance of the semantic similarity networks
and the HPRD network in the validation experiments.
Candidate genes are selected from the overlap of the
semantic similarity and the HPRD networks
Resnik
(%)
Schlicker
(%)
Lin
(%)
Wang
(%)
HPRD
(%)
Linkage
interval
MRR 10.60 10.86 10.97 11.05 14.21
AUC 90.30 90.04 89.93 89.85 86.65
Random genes
MRR 10.65 10.92 11.06 11.20 14.40
AUC 90.25 89.98 89.84 89.70 86.46
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genes and a linkage interval and present the results in
Table 2. In the validation against a linkage interval, we
obtain an MRR of 10.41% and an AUC of 90.50%. In
the validation against random genes, we obtain an MRR
of 10.19% and an AUC of 90.72%. These results clearly
suggest the high accuracy of relying on the gene seman-
tic similarity network to infer disease genes.
We further increase the number of random genes in
each validation run to 999 and find the AUC only drop
slightly to 90.36%, suggesting that the prioritization
method is not sensitive to the number of control genes
in validation. With this understanding, we pursue a
more ambitious goal of genome-wide scan for disease
genes and obtain an MRR of 10.16% and an AUC of
90.10% in uncovering the disease genes from all 14,085
genes in the gene semantic similarity network.
We then look at in detail the distribution of disease
genes ranked within top 100 of the 14, 085 genes and
present the results in Figure 6. We observe that 1, 602
(52.58%) diseases genes are ranked in top 100 when
relying on the network constructed using the method of
Resnik. Within these disease genes, 974 (31.97%) are
ranked in top 10, 182 (5.97%) ranked between 11 and
20, 114 (3.74%) ranked between 21 and 30, 85 (2.79%)
ranked between 31 and 40, and 72 (2.36%) ranked
between 41 and 50. In the zoomed-in plot of Figure 6,
we observe 192 (6.30%) disease genes ranked first, 295
(9.68%) ranked second, 120 (3.94%) genes ranked third,
95 (3.12%) genes ranked fourth, and 77 (2.53%) genes
ranked fifth. Furthermore, we find that the logarithm of
the number of genes at a rank fits a linear model with
the rank (log(#{genes}) = 5.72 – 0.26 × rank), and the
model is statistically significant with a r
2 of 0.9383 and a
p-value of 4.059 × 10
–6. These results suggest the effec-
tiveness of relying on the gene semantic similarity net-
work to scan genes potentially associated with a query
disease from the whole genome. Particularly, for query
diseases whose genetic bases completely unknown (and
thus no linkage information is available), researchers can
relying on the semantic similarity network to perform a
genome-wide scan and then focus on top ranked genes
to narrow down the scope of searching for disease
genes.
We also notice that relying on semantic similarity net-
works constructed using the other methods (with default
threshold values) yields similar results as we analyzed
above (Table 2).
Conclusions and discussion
In this paper, we have proposed to rely on the biological
process domain of gene ontology and GO annotations
Figure 4 ROC curves of the proposed approach. A: results for the validation of a linkage-interval. B: results for the validation of random genes.
Figure 5 Influence of the parameter  to the performance of the random walk model in the validation of a linkage interval. Solid lines represent
criteria obtained at different  values. Dot-dash lines represent baseline values of the criteria.
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work of genes, and then use the network with pheno-
type similarity network of diseases to infer genes that
are associated with a query disease of interest.
The main objective of this research is to overcome
one of the shortcomings of existing protein-protein
interaction networks, i.e., the low coverage. The con-
structed gene semantic similarity network covers 14,085
genes, about 50% more than the widely used HPRD net-
work. More importantly, as demonstrated in our com-
prehensive analysis, the improvement in coverage is
accompanied by the gain in accuracy in the inference of
disease genes. Hence, the gene semantic similarity net-
work can serve as a better assessment of functional rela-
tionship between genes and then be used in a large
number of applications in systems biology.
The filtration of low semantic similarity scores is
important to the success of the proposed approach. We
currently achieve this goal by keeping the first  nearest
neighbors of each gene. Alternatively, we can introduce
a threshold and discard all edges whose weight (similar-
ity score) is less than the threshold. According to our
experiments, this alternative strategy is likely to yield a
disconnected network and thus adversely affect the per-
formance of a prioritization method relying on the
network. Therefore, we resort to the nearest neighbor
strategy to filter out low semantic similarity scores.
Certainly, our research can further be improved from
the following aspects. First, although we have focused
on the biological process domain in this paper, it is
conceptually straightforward to use the molecular
function and the cellular component domains to con-
struct gene semantic similarity networks. According to
our experiments, semantic similarity networks relying
on these two gene ontology domains have similar cov-
erage as that of the biological process domain and can
achieve comparable performance as the HPRD network
in the inference of disease genes (data not shown).
Therefore, a possible improvement of our approach is
to construct a gene semantic similarity network with
the integration of all three domains in the gene
ontology.
Second, the semantic similarity network and the pro-
tein-protein interaction network assess the functional
relationship between genes from different points of
v i e w .T h e r e f o r e ,t h ei n f e r e n c eo fd i s e a s eg e n e sm a yb e
benefit from the integrated use of these two types of
networks. Furthermore, as the effectiveness of relying on
the “guilt-by-association” principle (without using the
phenotype similarity profile) and multiple genomic data
to infer disease genes has been demonstrated in pre-
v i o u ss t u d i e s .I ti sr e a s o n a b l et op u r s u et h eg o a lo f
using the phenotype similarity profile with multiple
genomic data to achieve more accurate inferences of
disease genes.
Methods
Calculation of semantic similarity scores
We adopt three methods based on information contents
of GO terms (Resnik [23], Schlicker et al. [24] and Lin
[25]) and one method based on the structure of gene
ontology (Wang et al. [26]) to calculate semantic simi-
larity scores between GO terms.
Given the gene ontology and annotations of human
genes, the probability of occurrence of a GO term t in
annotations, p(t), is estimated as the number that the
term or its descendants are used in annotations divided
by the total number of annotations, as
Table 2 Performance of the semantic similarity networks
in the validation experiments. Candidate genes are
selected from the semantic similarity networks.
Resnik (%) Schlicker (%) Lin (%) Wang (%)
Linkage interval
MRR 10.41 10.70 10.84 10.95
AUC 90.50 90.20 90.06 89.95
Random genes
MRR 10.19 10.48 10.62 10.79
AUC 90.72 90.42 90.68 90.11
Random genes (999)
MRR 10.14 10.49 10.60 10.81
AUC 90.36 90.01 89.91 89.69
Genome-wide scan
MRR 10.16 10.49 10.60 10.81
AUC 90.10 89.77 89.66 89.45
Figure 6 The distribution of genes ranked in top 100 in the genome-wide scan of disease genes.
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With the semantic similarity scores between GO
terms calculated by either of the above methods, we cal-
culate the semantic similarity between two genes as fol-
lows. The semantic similarity score between a GO term
t and a set of GO terms  is calculated as
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The semantic similarity score between two sets of GO
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Let g and g′ be two genes. Let () g and () ′ g be the
two sets of GO terms with which g and g′ are annotated,
respectively. The semantic similarity between g and g′ is
then calculated as
Sim Sim ( , ) ( ( ), ( )). gg g g ′ = ′ 
Applying the above method to every pair of genes, we
obtain a pairwise semantic similarity matrix of genes.
Certainly, this matrix can be thought of as the weight
matrix of a fully connected network, whose vertices are
genes and whose edges represent semantic similarity
scores between genes. However, such a fully connected
network may contain a large number of low confident
edges between gene pairs with low semantic similarity
scores. We therefore furtherf i l t e ro u te d g e sw i t hl o w
weights (similarity scores) in the fully connected net-
work by introducing a threshold  (defaulting to 100 in
this paper) and keeping only the first  nearest neigh-
bors for each gene. By doing this, we obtain a gene
semantic similarity network.
Prioritization of candidate genes
The random walk with restart on the heterogeneous
network model [17] is one of the state-of-the-art meth-
ods that utilize a disease similarity network with a pro-
tein-protein interaction network to prioritize candidate
genes. This model simulates the process that a random
walker wanders on a heterogeneous network composed
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interaction network, and known associations between
diseases and genes. In each step of the process, the ran-
dom walker may start on a new journey with probability
g or move on with probability 1 – g.W h e ns t a r t i n go n ,
the walker may choose the query disease of interest as
the starting point with probability h or choose a seed
g e n ek n o w nt ob ea s s o c i a t e dw i t ht h eq u e r yd i s e a s e
with probability 1 – h. When moving on, the walker
may choose to jump from the disease similarity network
to the protein-protein interaction network or vice versa
with probability l or choose to wander in either the dis-
ease network or the protein-protein interaction network
with probability 1 – l. When wandering about, the
walker moves at random to one of its direct neighbors.
In this model, the protein-protein interaction network
serves as a simplified yet systematic view of functional
relationships among genes. Since a gene semantic simi-
larity network also provides a means of measuring func-
tional relationships among genes, conceptually we can
also use a gene semantic similarity network with the
phenotype similarity network to infer disease genes. Fol-
l o w i n gt h el i t e r a t u r e[ 1 7 ] ,w eu s et h ef o l l o w i n gr a n d o m
walk with restart model on the heterogeneous network
that is composed of a phenotype similarity network, a
gene semantic similarity network, and known associa-
tions between diseases and genes.
We represent the phenotype similarity network using
aw e i g h tm a t r i xD =( dij)m×m,w h e r em denotes the
number of diseases and dij the similarity score between
the i-th disease and the j-th disease. By normalizing
each row of this matrix, we obtain a transition matrix U
=( uij)m×m,w h e r eud d ij ij ij j
m
=
= ∑ 1 ,r e p r e s e n t i n gt h e
probability that a random walker moves from the i-th
disease to the j-th disease.
We represent the gene semantic similarity network
using a weight matrix G =( gij)n×n,w h e r en denotes the
number of genes and gij the similarity score between the
i-th gene and the j-th gene. By normalizing each row of
this matrix, we obtain a transition matrix V =( vij)n×n,
where vg g ij ij ij j
n
=
= ∑ 1 , representing the probability that
a random walker moves from the i-th gene to the j-th
gene.
We represent known associations between diseases
and genes using an adjacency matrix A =( aij)m×n, where
aij = 1 indicates that the j-th gene is known to be asso-
ciated with the i-th disease, and aij =0o t h e r w i s e .B y
normalizing each row of this matrix, we obtain a transi-
tion matrix R =( rij)m×n,w h e r e ra a ij ij ij j
n
=
= ∑ 1 ,r e p r e -
senting the probability that a random walker jumps
from the i-th disease to the j-th gene. Note that we
define rij =0w h e n aij j
n
= ∑ =
1
0, i.e., when there is no
gene known as associated with the i-th disease.
Similarly, by normalizing each row of the transpose of
the matrix A, we obtain a transition matrix S =( sij)n×m,
where sa a ij ji ji j
m
=
= ∑ 1 , representing the probability that
a random walker jumps from the i-th gene to the j-th
disease. We also define sij =0w h e n aji j
m
= ∑ =
1
0 i.e.,
when the i-th gene is not associated with any disease.
With the above four transition matrices, we define
T
UR
SV
=
−
−
⎡
⎣
⎢
⎤
⎦
⎥
()
()
,
1
1
ll
ll
and further normalize every row of this matrix to
obtain the transition matrix of the heterogeneous net-
work W =( wij), where wt t ij ij ij j
mn
=
=
+ ∑ 1 . The parameter
l is the probability that the random walker jumps from
the disease similarity network to the gene semantic
similarity network or vice versa.
When the random walker starts in the disease similar-
ity network, we let it start from the query disease, there-
fore the initial probability is 1 for the query disease and
0 for other diseases. We use a vector u
(0) to represent
these probabilities. When the random walker starts in
the gene similarity network, we let it start at random
from one of the genes known as associated with the
query disease, therefore the initial probability is 1/s for
e v e r ys e e dg e n e( s u p p o s et h e r ea r eat o t a lo fs seed
genes) and 0 for other genes. We use a vector v
(0) to
represent these probabilities. Let h be the probability
that the random walker starts from the disease similarity
network, we have the initial probability vector
p
u
v
()
()
() ()
.
0
0
0 1
=
−
⎡
⎣
⎢
⎢
⎤
⎦
⎥
⎥
h
h
Finally, let p
(t) be the vector composed of probabilities
of finding the random walker at all vertices in the het-
erogeneous network at step t, we have
pW p p
() ( ) ( ) () .
tT t + =− +
10 1 gg
After a number of steps, the probability will reach a
steady state. This is obtained by performing the iteration
until the difference between p
(t) and p
(t+1) is sufficiently
small (i.e., the L1 norm of Δp = p
(t+1) – p
(t) is less than
a small positive number ε). The steady-state probability
p
(∞) then gives a measure of the strength of association
of each gene to the query disease of interest, and we
can then rank candidate genes according to their
steady-state probabilities.
It has been show that the random walk model is not
sensitive to the parameters involved in the model [17].
Hence, we follow the literature [17] and default the
parameters to l = 0.7, h = 0.5, g = 0.5 and ε =1 0
–4.
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We perform three large-scale leave-one-out cross-valida-
tion experiments to examine the performance of the
proposed method in prioritizing genes that are known
to be associated with certain diseases (i.e., disease genes)
from a set of candidates. First, in the validation against
a linkage interval, we take a known association between
a gene and a disease in each run, assume the association
is unknown, and prioritize the gene against a set of 99
control genes that locate nearest to the disease gene
according to their genomic distance on the same chro-
mosome. Second, in the validation against random
genes, we select control genes in each validation run as
9 9( o r9 9 9 )g e n e st h a ta r es e l e c t e da tr a n d o mf r o ma l l
genes in a gene semantic similarity network. Third, in
the genome-wide scan of disease genes, we select con-
trol genes in each validation run as all genes in a gene
semantic similarity network.
We use two measures to evaluate the performance of
the proposed method. Taking the cross-validation
against a linkage interval as an example, after each vali-
dation run, we obtain a score (the steady-state probabil-
ity) for each candidate gene and further rank genes
according to their scores (ties are broke by assigning
ranks to genes with equal scores at random) to obtain a
ranking list of candidate genes. We then calculate rank
ratios of candidate genes by dividing their ranks with
the number of candidate genes in the list. For a set of
validation runs, we calculate the following two measures.
First, we calculate the mean rank ratio (MRR) of all dis-
ease genes as the average of rank ratios of all disease
genes in the validation runs. Second, given a threshold
of rank ratio, we calculate the sensitivity as the fraction
of disease genes ranked above the threshold and the
specificity as the fraction of control genes ranked below
the threshold. Varying the threshold value from 0.0 to
1.0, we are able to draw a receiver operating characteris-
tic (ROC) curve and further calculate the area under
this curve (AUC). Obviously, smaller MRR and larger
AUC values indicate higher performance of a prioritiza-
tion method.
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